Literature DB >> 8020558

Control of Mac-2 surface expression on murine macrophage cell lines.

S Sato1, R C Hughes.   

Abstract

Mac-2 antigen, a 32-kDa murine macrophage cell-surface protein expressed on thioglycollate-elicited peritoneal exudate cells at higher levels than other macrophages, is a member of the S-(soluble) galactoside-binding lectin family with homologies to carbohydrate-binding proteins of other cell types. Murine macrophage cell lines can be ordered in a linear differentiation sequence according to their expression of Mac-2 and other surface markers (Leenen et al., Differentiation 1986. 32: 157.) We show here that antigen expression in macrophage cell lines can be regulated at the level of protein secretion. WEHI-3 cells, classified as immature macrophages by virtue of their low level of surface Mac-2 expression synthesize similar amounts of the antigen as more mature J774.2 and P388.D1 cells that express high amounts of surface Mac-2, but unlike these latter cell lines WEHI-3 cells fail to secrete the protein. Exogenously added Mac-2 binds efficiently to WEHI-3 cells and putative Mac-2-binding carbohydrates are expressed equally on WEHI-3, J774.2 and P388.D1 cells as judged by binding of plant lectins of known carbohydrate-binding specificities. Mac-2 secretion and surface expression in WEHI-3 cells is not significantly enhanced by calcium ionophore A23187, a powerful stimulator of Mac-2 secretion in other cells and a moderate stimulator in J774.2 and P388.D1 cells. WEHI-3 cells provide a valuable system for studying the mechanism of intracellular transport and secretion of Mac-2, a protein that lacks a signal sequence and does not enter the classical secretory pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020558     DOI: 10.1002/eji.1830240134

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 2.  Nuclear transport of galectin-3 and its therapeutic implications.

Authors:  Tatsuyoshi Funasaka; Avraham Raz; Pratima Nangia-Makker
Journal:  Semin Cancer Biol       Date:  2014-03-19       Impact factor: 15.707

3.  Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen).

Authors:  S Dong; R C Hughes
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

4.  Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.

Authors:  Maurice Nachtigal; Abdul Ghaffar; Eugene P Mayer
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

5.  Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3.

Authors:  M Guévremont; J Martel-Pelletier; C Boileau; F-T Liu; M Richard; J-C Fernandes; J-P Pelletier; P Reboul
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

6.  Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages.

Authors:  F T Liu; D K Hsu; R I Zuberi; I Kuwabara; E Y Chi; W R Henderson
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

7.  Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Authors:  Caroline Toudic; Amandine Vargas; Yong Xiao; Guillaume St-Pierre; Norbert Bannert; Julie Lafond; Éric Rassart; Sachiko Sato; Benoit Barbeau
Journal:  FASEB J       Date:  2019-09-07       Impact factor: 5.191

Review 8.  IgE and mast cells in allergic disease.

Authors:  Stephen J Galli; Mindy Tsai
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

9.  Regulation of tumor progression by extracellular galectin-3.

Authors:  Pratima Nangia-Makker; Vitaly Balan; Avraham Raz
Journal:  Cancer Microenviron       Date:  2008-02-20

10.  Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.

Authors:  Simone Kloch Bendtsen; Maria Perez-Penco; Mie Linder Hübbe; Evelina Martinenaite; Morten Orebo Holmström; Stine Emilie Weis-Banke; Nicolai Grønne Dahlager Jørgensen; Mia Aaboe Jørgensen; Shamaila Munir Ahmad; Kasper Mølgaard Jensen; Christina Friese; Mia Thorup Lundsager; Astrid Zedlitz Johansen; Marco Carretta; Niels Ødum; Özcan Met; Inge Marie Svane; Daniel Hargbøl Madsen; Mads Hald Andersen
Journal:  Oncoimmunology       Date:  2022-01-27       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.